Andrew Joseph - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Andrew Joseph's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Andrew Joseph
Verified
Reporter, STAT
London
Beats
Biography
Andrew Joseph covers Kendall Square for STAT, writing about local research and neighborhood issues. He previously worked for the San Antonio Express-News, the San Francisco Chronicle, and the National Journal. Andrew graduated from Dartmouth College and has covered everything from crime to health policy. He's run a couple marathons, and one time got called out by Arnold Schwarzenegger at a press conference for asking a question that made no sense.
HR without the tech
Content
By Andrew Joseph Verified| STAT Verified GSK’s blood cancer drug Blenrep won regulatory approval in the U.K. on Thursday, marking the medicine’s return to the market after it was withdrawn several years ago. The drug, which treats multiple myeloma, will be used in combination with other medicines in patients whose cancer has resurged after an earlier line of treatment, under the approval from the Medicines and Healthcare products Regulatory Agency.
By Andrew Joseph Verified, Elaine Chen Verified| STAT Verified A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said Thursday, late-stage results that could propel the next-generation treatment onto the market. The drug, orforglipron, produced results that were nearly comparable to the benefits of available GLP-1 drugs, which are primarily weekly injectable treatments. Companies have been racing to develop more convenient, as well as more powerful, obesity treatments, including pills.
By Andrew Joseph Verified| STAT Verified LONDON — The U.K. government is starting to recognize that the country needs to change how it pays for medicines if it is to attract more investment from the pharmaceutical industry, a government official said Thursday. The pharma industry has for several years complained about the scheme under which the National Health Service buys medicines, with drug companies having to pay a portion of their sales back to the government when drug spending increases past a certain level.
Company Info
STAT
STAT News is a digital media outlet focused on health, medicine, and science journalism. Launched in 2015, it specializes in investigative reporting and analysis of medical advancements, pharmaceutical developments, and public health issues. The platform gained significant recognition during the COVID-19 pandemic for its comprehensive coverage, which helped expand its audience and revenue. The company provides in-depth news reporting, features, and opinion pieces from industry experts. It also hosts industry events and collaborates with healthcare organizations through brand partnerships. STAT News operates on a subscription model, offering premium content while temporarily removing paywalls for COVID-19 coverage to enhance public access. With an estimated annual revenue of $56.4 million, the company has seen substantial growth, particularly during the pandemic, and currently employs 364 people.
Boston, Massachusetts, United States
+1 617-929-2260
Founded: 2015